PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Clinical trials for PROGNOSTIC STAGE IV BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PROGNOSTIC STAGE IV BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for PROGNOSTIC STAGE IV BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made vaccine takes on tough breast cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study tests a personalized vaccine made from a patient's own tumor, combined with immunotherapy drugs, for triple negative breast cancer. The goal is to see if the vaccine is safe and can help the immune system attack cancer cells. About 18 adults with various st…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: Emory University • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 03:52 UTC
-
Electric field therapy worn like a vest shows promise against tough cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields to disrupt cancer cell growth, combined with standard drugs (cabozantinib or nab-paclitaxel plus atezolizumab). About 43 adults with advanced solid tumors in the abdomen or chest that have s…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:47 UTC
-
New vaccine combo aims to shrink breast cancer brain tumors
Disease control Recruiting nowThis study tests a combination of two treatments for people with breast cancer that has spread to the brain. One is a vaccine made from the patient's own immune cells, designed to help the body recognize and attack cancer. The other is a drug called pembrolizumab, which helps the…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New drug targets Hard-to-Treat cancers with specific mutations
Disease control Recruiting nowThis study tests a drug called avapritinib in people with advanced solid tumors that have spread and have specific gene changes (CKIT or PDGFRA mutations). The drug works by blocking enzymes that help cancer cells grow. The goal is to see if avapritinib can shrink or control thes…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New hope for hard-to-treat breast cancer: drug combo targets resistance
Disease control Recruiting nowThis study tests whether adding another drug (cediranib or AZD6738) to the PARP inhibitor olaparib can shrink tumors or slow cancer growth in people with advanced BRCA-mutated breast cancer that has stopped responding to PARP inhibitors. About 60 adults with HER2-negative, BRCA-p…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Can a Hair-Growing drug fix Chemo-Free hair loss?
Symptom relief Recruiting nowThis study tests whether minoxidil (a hair-growth drug) can reduce hair loss caused by hormone therapy in breast cancer patients. About 50 women with stages I-IV breast cancer who are on hormone therapy and have noticed hair thinning will take either a pill or apply a solution da…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 03:45 UTC
-
New hope for seniors: tolerability trial for advanced breast cancer drug
Symptom relief Recruiting nowThis study looks at how well older adults (70+) with hormone receptor positive metastatic breast cancer tolerate the drug abemaciclib after other treatments have stopped working. The main goal is to track side effects and see if the drug can be safely combined with hormone therap…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
700 breast cancer patients enrolled to unlock secrets of CDK4/6 drug resistance
Knowledge-focused Recruiting nowThis study follows 700 adults with advanced or metastatic breast cancer who are taking CDK4/6 inhibitors (ciclibs). Researchers collect blood, tissue, and fluid samples to understand how the cancer responds and why resistance develops. The goal is to improve treatment decisions a…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 03:37 UTC
-
Blood test monitoring may be as effective as scans for advanced breast cancer
Knowledge-focused Recruiting nowThis study is testing whether using simple blood tests (tumor markers) to decide when to do scans is as good as the usual approach of regular scans for people with advanced hormone receptor-positive breast cancer. About 739 participants will be randomly assigned to either blood t…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 18, 2026 12:01 UTC